Ahmed C. M., Chanda R. S., Stow N. D. and Zain B. S., 1982. The nucleotide sequence of
mRNA for the Mr 19 000 glycoprotein from early gene block III of adenovirus 2.
Gene 20, 339-346.
Altschul S. F., Gish W., Miller W., Myers E. W. and Lipman D. J., 1990. Basic Local
Alignment Search Tool. J. Mol. Biol. 215, 403-410.
Andersson M., McMichael A. and Peterson P. A., 1987. Reduced allorecognition of
adenovirus-2 infected cells. J. Immunol. 138, 3960-3966.
Beier D. C., Cox J. H., Vining D. R., Cresswell P. and Engelhard V. H., 1994. Association of
human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 152,
3862-3872.
Bennett E. M., Bennink J. R., Yewdell J. W. and Brodsky F. M., 1999. Cutting edge:
adenovirus E19 has two mechanisms for affecting class I MHC expression. J.
Immunol. 162, 5049-5052.
Bruder J. T., Jie T., McVey D. L. and Kovesdi I., 1997. Expression of gp19K increases the
persistence of transgene expression from an adenovirus vector in the mouse lung and
liver. J. Virol. 71, 7623-7628.
Bryson K., McGuffin L. J., Marsden R. L., Ward J. J., Sodhi J. S. and Jones D. T., 2005.
Protein structure prediction servers at university college london. Nucleic Acids
Research 33, W36-W38.
Burgert H.-G. and Blusch J. H., 2000. Immunomodulatory functions encoded by the E3
transcription unit of adenoviruses. Virus Genes 21, 13-25.
Burgert H.-G. and Kvist S., 1985. An adenovirus type 2 glycoprotein blocks cell surface
expression of human histocompatibility class I antigens. Cell 41, 987-997.
Burgert H.-G. and Kvist S., 1987. The E3/19K protein of adenovirus type 2 binds to the
domains of histocompatibility antigens required for CTL recognition. EMBO J. 6,
2019-2026.
Burgert H.-G., Maryanski J. L. and Kvist S., 1987. "E3/19K" protein of adenovirus type 2
inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of
histocompatibility class I antigens. Proc. Natl. Acad. Sci. U.S.A. 84, 1356-1360.
Burgert H.-G., Ruzsics Z., Obermeier S., Hilgendorf A., Windheim M. and Elsing A., 2002.
Subversion of host defense mechanisms by adenoviruses. Curr. Top. Microbiol.
Immunol. 269, 273-318.
Cole C., Barber J. D. and Barton G. J., 2008. The Jpred 3 secondary structure prediction
server. Nucleic Acids Research 36, in press.
Cox J. H., Bennink J. R. and Yewdell J. W., 1991. Retention of adenovirus E19 glycoprotein
in the endoplasmic reticulum is essential to its ability to block antigen presentation. J.
Exp. Med. 174, 1629-1637.
Deryckere F. and Burgert H.-G., 1996. Early region 3 of adenovirus type 19 (subgroup D)
encodes an HLA-binding protein distinct from that of subgroups B and C. J. Virol. 70,
2832-2841.
Edgar R. C., 2004. MUSCLE: multiple sequence alignment with high accuracy and high
throughput. Nucl. Acids Res. 32, 1792-1797.
Elsing A. and Burgert H.-G., 1998. The adenovirus E3/10.4K-14.5K proteins down-modulate
the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc. Natl. Acad. Sci.
U.S.A. 95, 10072-10077.
Feuerbach D., Etteldorf S., Ebenau-Jehle C., Abastado J. P., Madden D. and Burgert H.-G.,
1994. Identification of amino acids within the MHC molecule important for the
interaction with the adenovirus protein E3/19K. J. Immunol. 153, 1626-1636.
Flomenberg P., Gutierrez E. and Hogan K., 1994. Identification of class I MHC regions which
bind to the adenovirus E3-19k protein. Mol. Immunol. 31, 1277-1284.
Flomenberg P., Szmulewicz J., Gutierrez E. and Lupatkin H., 1992. Role of the adenovirus
E3-19k conserved region in binding major histocompatibility complex class I
molecules. J. Virol. 66, 4778-4783.
Fox J. P., Hall C. E. and Cooney M. K., 1977. The Seattle Virus Watch. VII. Observations of
adenovirus infections. Am. J. Epidemiol. 105, 362-386.
Gabathuler R., Levy F. and Kvist S., 1990. Requirements for the association of adenovirus
type 2 E3/19K wild-type and mutant proteins with HLA antigens. J. Virol. 64, 3679-
3685.
Gewurz B. E., Gaudet R., Tortorella D., Wang E. W., Ploegh H. L. and Wiley D. C., 2001.
Antigen presentation subverted: Structure of the human cytomegalovirus protein US2
bound to the class I molecule HLA-A2. Proc. Natl. Acad. Sci. USA 98, 6794-6799.
Ginsberg H. S., Lundholm Beauchamp U., Horswood R. L., Pernis B., Wold W. S., Chanock
R. M. and Prince G. A., 1989. Role of early region 3 (E3) in pathogenesis of
adenovirus disease. Proc. Natl. Acad. Sci. U.S.A. 86, 3823-3827.
Hermiston T. W., Tripp R. A., Sparer T., Gooding L. R. and Wold W. S., 1993. Deletion
mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of
sequences within the endoplasmic reticulum lumenal domain that are required for
class I antigen binding and protection from adenovirus-specific cytotoxic T
lymphocytes. J.Virol. 67, 5289-5298.
Hilgendorf A., Lindberg J., Ruzsics Z., Höning S., Elsing A., Löfqvist M., Engelmann H. and
Burgert H.-G., 2003. Two distinct transport motifs in the adenovirus E3/10.4-14.5
proteins act in concert to down-modulate apoptosis receptors and the epidermal
growth factor receptor. J. Biol. Chem. 278, 51872-51884.
Jackson M. R., Nilsson T. and Peterson P. A., 1990. Identification of a consensus motif for
retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9, 3153-
3162.
Jackson M. R., Nilsson T. and Peterson P. A., 1993. Retrieval of transmembrane proteins to
the endoplasmic reticulum. J. Cell Biol. 121, 317-333.
Jefferies W. A. and Burgert H.-G., 1990. E3/19K from adenovirus 2 is an immunosubversive
protein that binds to a structural motif regulating the intracellular transport of major
histocompatibility complex class I proteins. J. Exp. Med. 172, 1653-1664.
Köhler G. and Milstein C., 1975. Continuous cultures of fused cells secreting antibody of
predefined specificity. Nature 256, 495-497.
Körner H., Fritzsche U. and Burgert H.-G., 1992. Tumor necrosis factor alpha stimulates
expression of adenovirus early region 3 proteins: implications for viral persistence.
Proc. Natl. Acad. Sci. U.S.A. 89, 11857-11861.
Kornfeld R. and Wold W. S., 1981. Structures of the oligosaccharides of the glycoprotein
coded by early region E3 of adenovirus 2. J. Virol. 40, 440-449.
Krogh A., Larsson B., von Heijne G. and Sonnhammer E. L. L., 2001. Predicting
transmembrane protein topology with a hidden Markov model: Application to
complete genomes. J. Mol. Biol. 305, 567-580.
Kurowski M. A. and Bujnicki J. M., 2003. GeneSilico protein structure prediction metaserver.
Nucl. Acids Res. 31, 3305-3307.
Lichtenstein D. L., Toth K., Doronin K., Tollefson A. E. and Wold W. S., 2004. Functions
and mechanisms of action of the adenovirus E3 proteins. Int. Rev. Immunol. 23, 75-
111.
Liu H., Fu J. and Bouvier M., 2007. Allele- and Locus-Specific Recognition of Class I MHC
Molecules by the Immunomodulatory E3-19K Protein from Adenovirus. J. Immunol.
178, 4567-4575.
Liu H., Stafford W. F. and Bouvier M., 2005. The endoplasmic reticulum lumenal domain of
the adenovirus type 2 E3-19K protein binds to peptide-filled and peptide-deficient
HLA-A*1101 molecules. J. Virol. 79, 13317-13325.
Lodoen M. B. and Lanier L. L., 2005. Viral modulation of NK cell immunity. Nat. Rev.
Micro. 3, 59-69.
Mans J., Natarajan K., Balbo A., Schuck P., Eikel D., Hess S., Robinson H., Simic H., Jonjic
S., Tiemessen C. T. and Margulies D. H., 2007. Cellular Expression and Crystal
Structure of the Murine Cytomegalovirus Major Histocompatibility Complex Class Ilike
Glycoprotein, m153. J. Biol. Chem. 282, 35247-35258.
McNees A. L. and Gooding L. R., 2002. Adenoviral inhibitors of apoptotic cell death. Virus
Res. 88, 87-101.
McSharry B., Burgert H.-G, Owen D. P., Stanton R., Prod'homme V., Sester M., Koebernick
K., Groh V., Spies T., Cox S., Little A. M., Wang E. C., Tomasec P. and Wilkinson G.
W., 2008. Adenovirus E3/19K Promotes Evasion of NK Cell Recognition by
Intracellular Sequestration of the NKG2D Ligands MICA and MICB. J. Virol. 80, in
press.
Nilsson T., Jackson M. and Peterson P. A., 1989. Short cytoplasmic sequences serve as
retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 58,
707-718.
Pääbo S., Bhat B. M., Wold W. S. and Peterson P. A., 1987. A short sequence in the COOHterminus
makes an adenovirus membrane glycoprotein a resident of the endoplasmic
reticulum. Cell 50, 311-317.
Pääbo S., Nilsson T. and Peterson P. A., 1986a. Adenoviruses of subgenera B, C, D, and E
modulate cell-surface expression of major histocompatibility complex class I antigens.
Proc. Natl. Acad. Sci. U.S.A. 83, 9665-9669.
Pääbo S., Weber F., Nilsson T., Schaffner W. and Peterson P. A., 1986b. Structural and
functional dissection of an MHC class I antigen-binding adenovirus glycoprotein.
EMBO J. 5, 1921-1927.
Persson H., Jansson M. and Philipson L., 1980. Synthesis and genomic site for an adenovirus
type 2 early glycoprotein. J. Mol. Biol. 136, 375-394.
Rawle F. C., Tollefson A. E., Wold W. S. and Gooding L. R., 1989. Mouse anti-adenovirus
cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. J.
Immunol. 143, 2031-2037.
Rost B., Fariselli P. and Casadio R., 1996. Topology prediction for helical transmembrane
proteins at 86% accuracy. Protein Science 5, 1704-1718.
Rost B. and Sander C., 1993. Prediction of Protein Secondary Structure at Better than 70%
Accuracy. J. Mol. Biol. 232, 584-599.
Rost B., Yachdav G. and Liu J. F., 2004. The PredictProtein server. Nucl. Acids Res. 32,
W321-W326.
Sester M. and Burgert H.-G., 1994. Conserved cysteine residues within the E3/19K protein of
adenovirus type 2 are essential for binding to major histocompatibility complex
antigens. J. Virol. 68, 5423-5432.
Sester M., Feuerbach D., Frank R., Preckel T., Gutermann A. and Burgert H.-G., 2000. The
amyloid precursor-like protein 2 associates with the major histocompatibility complex
class I molecule K(d). J. Biol. Chem. 275, 3645-3654.
Tanaka Y. and Tevethia S. S., 1988. Differential effect of adenovirus 2 E3/19K glycoprotein
on the expression of H-2Kb and H-2Db class I antigens and H-2Kb- and H-2Dbrestricted
SV40-specific CTL-mediated lysis. Virology 165, 357-366.
The_UniProt_Consortium. 2007. The Universal Protein Resource (UniProt). Nucl. Acids Res.
35, D193-D197.
von Herrath M. G., Efrat S., Oldstone M. B. and Horwitz M. S., 1997. Expression of
adenoviral E3 transgenes in beta cells prevents autoimmune diabetes. Proc. Natl.
Acad. Sci. U.S.A. 94, 9808-9813.
Windheim M., Hilgendorf A. and Burgert H.-G., 2004. Immune evasion by adenovirus E3
proteins: exploitation of intracellular trafficking pathways. Curr. Top. Microbiol.
Immunol. 273, 29-85.
Wold W. S., Cladaras C., Deutscher S. L. and Kapoor Q. S., 1985. The 19-kDa glycoprotein
coded by region E3 of adenovirus. Purification, characterization, and structural
analysis. J. Biol. Chem. 260, 2424-2431.
Wold W. S. M. and Horwitz M. S. (2007) Adenoviruses. In Fields Virology (Edited by Knipe
D. M., Howley P. M., Griffin D. E. and Lamb R. A.), p. 2395-2436. Lippincott
Williams & Wilkins.